Vanguard Global Advisers
PFE icon

Vanguard Global Advisers’s Pfizer PFE Stock Holding History

Vanguard Global Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$368M Buy
12,914,601
+119,543
+0.9% +$3.18M 0.16% 88
2026
Q2 		$308M Sell
12,795,058
-110,838
-0.9% -$2.9M 0.14% 102
2026
Q1 		$362M Buy
+12,905,896
New +$344M 0.19% 81

Other funds holding PFE

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Vanguard Global Advisers's PFE Position: Q3 2026 in Review

Vanguard Global Advisers increased its Pfizer (PFE) stake by 0.93% in Q3 2026, buying an estimated $3.18M and bringing the position to 12,914,601 shares worth $368M. The position accounts for 0.16% of the portfolio, ranked #88.

Vanguard Global Advisers first reported a position in PFE in Q1 2026 and has held it in 3 quarters since. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Vanguard Global Advisers held 12,914,601 shares of Pfizer worth $368M as of Q3 2026.
  • Vanguard Global Advisers bought 119,543 Pfizer shares in Q3 2026, an estimated $3.18M.
  • Pfizer made up 0.16% of Vanguard Global Advisers's portfolio in Q3 2026, its #88 holding.
  • Vanguard Global Advisers first reported a position in Pfizer in Q1 2026 and has held it in 3 quarters since.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.